Enrollment for the RESOLVE-AF trial in the Czech Republic is off to a great start! Principal Investigator Prof. Petr Neuzil and Sub-Investigator Dr. Jan Petru and their team completed their first 6 cases at Homolce Hospital this week.
Visit CortexEp.com to learn more
1st cases in Czech Republic! Congrats to Dr. Martin Fiala and his colleagues at Neuron Medical in Brno for completing their 1st procedures using the OptiMap™ System today! This initiates the 1st Czech site in the RESOLVE-AF clinical trial. CortexEP.com
#EPeeps #EP #AF
Congrats to @tomdepotter & the #EPeeps at @OLVZaalst for completing their first 2 procedures using the OptiMap™ System today! This initiates the second site in Belgium in the RESOLVE-AF clinical trial. We're delighted to have Dr. de Potter & @OLVZaalst in this study!
First in Belgium! Congrats to Dr. Michael Wolf and the #EPeeps at ZNA - Ziekenhuis Netwerk Antwerpen for performing Belgium's first procedure using the OptiMap™ System, as part of the RESOLVE-AF clinical trial.
The conversations we had with the hundreds of physicians and industry professionals who came by our booth at #HRS2024 confirms our belief that the OptiMap™ System will fill a vital unmet need for understanding the underlying pathophysiology of AF, esp. in complex redo cases.
Join us TOMORROW at #HRS2024 for a Rhythm Theater presentation.
Hear from @atulverma_md, @Kent_Nilsson_EP, Dr. Ilana Kutinsk, & @su_wilber how Electrographic Flow™ mapping with the OptiMap™ System is being used by physicians in complex AF cases.
#Epeeps #EP
Join us at #HRS2024 for a Rhythm Theater presentation.
Hear from @atulverma_md, @Kent_Nilsson_EP, Dr. Ilana Kutinsky & @su_Wilber how Electrographic Flow™ mapping with the OptiMap™ System is being used by physicians in complex AF cases.
#Epeeps #EP
We look forward to seeing you in Boston at #HRS2024!
Visit our booth to learn about the 510(k) cleared OptiMap™ System, an Electrographic Flow™ (EGF) mapping solution designed with AI that enables physicians to See What Matters.
See all of our events: cortexep.com/hrs-2024
The international RESOLVE-AF trial enrolled its first EU patient today as Dr. Max Liebregts completed the first case. @boersma_lucas, the EU PI, said, “I’m excited to participate in this study to evaluate Cortex’s EGF mapping as promising approach to identify extra-PV sources.”









